The below piece is based on the resource: How FDA and the Omnibus Bill Will Reshape Pre & Post Market Prod […]
This article is based on Adam Shostack’s interview on the Left to Our Own Devices podcast. Adam S […]
What will your team do if a software component or a supplier’s entire software suite becomes untrustwort […]
Phil Englert was ahead of the curve in introducing cybersecurity into the medical device industry, building me […]
VEX reports have finally hit the mainstream and the excitement surrounding them has as much to do with automat […]
Part 1: Using SBOMs for enhanced visibility and control The dynamic nature of software development exposes th […]
Advanced workflow, approval process and management dashboard enhance control, distribution and supervision, wh […]
Shlomi Ashkenazy and David Leichner recap the highlights of the past year and light the beacon for Product Sec […]
Is open source software, one of the great wonders of our time, setting us up for one of the great cybersecurit […]